Aya AL-ibraheemi1, Mustafa Zakaria2*, Mohamed Zarqaoui3, Mohamed Ennaji4, Wassym R Senhaji5, Ritu S Santwani6, Nisrine En-naciri7, Hafida Tarik7, Romaissa Boutiche8 and Noureddine Louanjli9
1Embryologist, Graduated from University of Nottingham, United Kingdom, with a MMedSci Degree in Assisted Reproductive Technology and a Researcher in the Art Irifiv Scientific Research Group, UK
2Head of LABOMAC Laboratory of Clinical Analysis and Assisted Reproductive Technology IRIFIV Fertility Center, AFC Fertility Center - Executive Vice President of the ART IRIFIV Scientific Research Group (AISRG) Casablanca, Morocco
3Endoscopic Surgery Obstetrics and Gynecology FR, Coordinator of IRIFIV Fertility Center, Head of the ART IRIFIV Scientific Research Group (AISRG) Casablanca, Morocco
4Senior Clinical Embryologist at IRIFIV Fertility Center, Member of the Scientific Research Group and Researcher in the Scientific Research Group, Casablanca, Morocco
5Gynecologist and Obstetrician, Endoscopic Surgeon and Fertility Expert, A Research in Art Irifiv Scientific Research Group Associated Practitioner at IRIFIV Fertility Center – Casablanca, Morocco
6Gynaecologist and Obstetrician, ART-Singapore, Honorary Professor, Obs and Genec - VIMS Medical College, Garjula – India Society for Assisted Reproduction (ISAR).is a researcher in the Art Irifiv Scientific Research Group, India
7Senior Clinical Embryologist, Laboratory IVF Agadir, Souss-Massa, Member of the Scientific Research Group and Researcher in the Scientific Research Group, Agadir, Morocco
8Senior Clinical Embryologist, Laboratory IVF Algeria, Rotaby Fertility Center Algiera - Algiers, Member of the Scientific Research Group and researcher in the Scientific Research Group, Algeria
9Reproductive Biology, and Assisted Reproductive Technology, Consultant at IRIFIV Fertility Center, Administrative Deputy and Writer for the ART IRIFIV Scientific Research Group (AISRG) Casablanca, Morocco
*Corresponding Author: Mustafa Zakaria, Consultant at IRIFIV Fertility Center, Administrative Deputy and Writer for the ART IRIFIV Scientific Research Group (AISRG), Casablanca, Morocco.
Received: January 15, 2021; Published: January 28, 2021
Male infertility count for almost 30% of the total cases of infertility. Male infertility can be caused by several and various factors such as environmental, genetics and hormonal factors. Male infertility can be diagnosed through semen sample analysis; a fresh semen sample can indicate different semen abnormalities. A semen sample can indicate Azoospermia, Cryptozoospermia (Co) or Severe Oligozoospermia (ESO), who can cause infertility in male. It is challenging for an andrologist to distinguish between ESO and CO in clinic diagnose since both of them show no sperm in the sample in the initial sample test. In Cryptozoospermia or Severe Oligozoospermia, cryopreservation plays a significant part in preserving male fertility by freezing the individual sperm.
Keywords: Male Infertility; Semen Analysis; Abnormal Semen Sample; Cryptozoospermia and Cryopreservation
Citation: Mustafa Zakaria., et al. “Male Infertility in Cryptozoospermia or Severe Oligozoospermia is sperm Useful Cryopreservation”. Acta Scientific Women's Health 3.2 (2021): 51-56.
Copyright: © 2021 Mustafa Zakaria., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.